Image created using Adobe Illustrator
14. Shi, X., Reinstadler, B., Shah, H., To, T.L., Byrne, K., Summer, L., Calvo, S.E., Goldberger, O., Doench, J.G., Mootha, V.K., and Shen, H
Yasui K, Baba A (2006) Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation
This mechanism is fundamentally different from GLP-1 medications, produces smaller weight loss, and carries different risks
- Maintaining the health and immune system
The "Start Low" Approach (Resetting to Introduction Doses) Semaglutide and tirzepatide both follow titrated dosing schedules, where healthcare providers prescribe a low starting dose and gradually increase from there based on your response to the medication and tolerance for side effects